Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.5M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
9.69M
-
Shares change
-
-60.6K
-
Total reported value, excl. options
-
$146M
-
Value change
-
-$989K
-
Number of buys
-
21
-
Number of sells
-
-15
-
Price
-
$15.04
Significant Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q4 2020
48 filings reported holding TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share as of Q4 2020.
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.69M shares
of 44.5M outstanding shares and own 21.76% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.03M shares), Essex Woodlands Management, Inc. (1.48M shares), RTW INVESTMENTS, LP (1.38M shares), COWEN AND COMPANY, LLC (402K shares), VANGUARD GROUP INC (399K shares), Opaleye Management Inc. (365K shares), Alyeska Investment Group, L.P. (347K shares), PURA VIDA INVESTMENTS, LLC (309K shares), BlackRock Inc. (307K shares), and Pentwater Capital Management LP (282K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.